Intra-coronary high-dose CD34+ stem cells in patients with chronic ischemic heart disease: a 12-month follow-up

AJ Boyle, R Whitbourn, S Schlicht, H Krum… - International journal of …, 2006 - Elsevier
Current stem cell protocols for ischemic heart disease are limited by the small numbers of
cells that can be obtained by bone marrow aspirate. To increase myocardial delivery of bone …
被引用次数：126 相关文章

[引用][C] Intra-coronary high-dose CD34+ stem cells in patients with chronic ischemic heart disease: A 12-month follow-up

AJ BOYLE, R WHITBOURN… - International journal …, 2006 - pascal-francis.inist.fr
Intra-coronary high-dose CD34+ stem cells in patients with chronic ischemic heart disease :
A 12-month follow-up CNRS Inist Pascal-Francis CNRS Pascal and Francis Bibliographic …

Intra-coronary high-dose CD34+ stem cells in patients with chronic ischemic heart disease: A 12-month follow-up

AJ Boyle, R Whitbourn… - International …, 2006 - internationaljournalofcardiology.com
Current stem cell protocols for ischemic heart disease are limited by the small numbers of
cells that can be obtained by bone marrow aspirate. To increase myocardial delivery of bone …

Intra-coronary high-dose CD34+ stem cells in patients with chronic ischemic heart disease: a 12-month follow-up.

AJ Boyle, R Whitbourn, S Schlicht, H Krum… - … Journal of Cardiology, 2005 - europepmc.org
Current stem cell protocols for ischemic heart disease are limited by the small numbers of
cells that can be obtained by bone marrow aspirate. To increase myocardial delivery of bone …
[PDF] academia.edu

[PDF][PDF] Intra-coronary high-dose CD34+ stem cells in patients with chronic ischemic heart disease: A 12-month follow-up

AJ Boyle, R Whitbourn, S Schlicht, H Krum… - International Journal of …, 2006 - academia.edu
Current stem cell protocols for ischemic heart disease are limited by the small numbers of
cells that can be obtained by bone marrow aspirate. To increase myocardial delivery of bone …

Intra-coronary high-dose CD34+ stem cells in patients with chronic ischemic heart disease: a 12-month follow-up

A Boyle, R Whitbourn, S Schlicht… - International …, 2006 - research.monash.edu
Current stem cell protocols for ischemic heart disease are limited by the small numbers of
cells that can be obtained by bone marrow aspirate. To increase myocardial delivery of bone …

Intra-coronary high-dose CD34+ stem cells in patients with chronic ischemic heart disease: A 12-month follow-up

AJ Boyle, R Whitbourn, S Schlicht, H Krum… - International Journal of …, 2006 - infona.pl
Current stem cell protocols for ischemic heart disease are limited by the small numbers of
cells that can be obtained by bone marrow aspirate. To increase myocardial delivery of bone …

[引用][C] Intra-coronary high-dose CD34+ stem cells in patients with chronic ischemic heart disease: A 12-month follow-up

AJ Boyle, R Whitbourn, S Schlicht, H Krum… - International Journal of …, 2006 - cir.nii.ac.jp
Intra-coronary high-dose CD34+ stem cells in patients with chronic ischemic heart disease: A
12-month follow-up | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細 …

Intra-coronary high-dose CD34+ stem cells in patients with chronic ischemic heart disease: a 12-month follow-up

AJ Boyle, R Whitbourn, S Schlicht… - International …, 2006 - pubmed.ncbi.nlm.nih.gov
Current stem cell protocols for ischemic heart disease are limited by the small numbers of
cells that can be obtained by bone marrow aspirate. To increase myocardial delivery of bone …
[PDF] academia.edu

[PDF][PDF] Intra-coronary high-dose CD34+ stem cells in patients with chronic ischemic heart disease: A 12-month follow-up

AJ Boyle, R Whitbourn, S Schlicht, H Krum… - International Journal of …, 2006 - academia.edu
Current stem cell protocols for ischemic heart disease are limited by the small numbers of
cells that can be obtained by bone marrow aspirate. To increase myocardial delivery of bone …